Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

AVECHO BIOTECHNOLOGY LIMITED

INVESTOR PRESENTATION - AVECHO BIOTECHNOLOGY LIMITED

ASX:AVE

AVECHO BIOTECHNOLOGY LIMITED

Health Care

Avecho Biotechnology Limited (AVE , formerly POH) develops and commercialises Human and Animal Health products using its proprietary drug delivery system called TPM (Targeted Penetration Matrix). Formerly Known: Phosphagenics Limited (POH )

Market Cap

12.78m

Price at Close

$0.008

4w avg. Volume

680.95k

4w avg. Turnover

$5.12k

Announcements
announcementt+2 movementdate
  • Receipt of R&D Tax Incentive

    Company Administration · Market sensitive

  • +14.29%

    16 Sep 2020

+14.29%

16 Sep 2020
  • Securities Trading Policy

    Other

  • -11.11%

    27 Aug 2020

-11.11%

27 Aug 2020
  • Appendix 4D and Half-year Financial Report

    Periodic Reports · Market sensitive

  • -11.11%

    27 Aug 2020

-11.11%

27 Aug 2020
  • Progress Update for TPM Cannabinoid Development Program

    Progress Report · Market sensitive

  • +12.50%

    19 Aug 2020

+12.50%

19 Aug 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    17 Aug 2020

0.00%

17 Aug 2020
  • June 2020 Quarterly Activities Report & Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    28 Jul 2020

0.00%

28 Jul 2020
  • Response to ASX Price Query

    ASX Query · Market sensitive

  • -27.27%

    22 Jul 2020

-27.27%

22 Jul 2020
  • 2020 Annual General Meeting Results

    Notice Of Meeting

  • 0.00%

    13 Jul 2020

0.00%

13 Jul 2020
  • CEO Presentation (AGM)

    Periodic Reports

  • 0.00%

    13 Jul 2020

0.00%

13 Jul 2020
  • Avecho Investor Update

    Periodic Reports

  • +14.29%

    15 Jun 2020

+14.29%

15 Jun 2020
Market Data

Current Price

$0.008

52WK HIGH

$0.012

52WK LOW

$0.002

1YR RETURN

+33.33%

1YR RETURN VS. SECTOR

+19.47%

90 DAY RETURN

+14.29%

ASX RANK

1,580

/2,017

SECTOR RANK

28

/31

SHARES OUTSTANDING

1.60b
ASX:AVE

AVECHO BIOTECHNOLOGY LIMITED

Health Care

Avecho Biotechnology Limited (AVE , formerly POH) develops and commercialises Human and Animal Health products using its proprietary drug delivery system called TPM (Targeted Penetration Matrix). Formerly Known: Phosphagenics Limited (POH )

Market Cap

12.78m

Price at Close

$0.008

4w avg. Volume

680.95k

4w avg. Turnover

$5.12k

ASX:AVE is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.